Ensure Safe Use of Antiarrhythmics for Atrial Fib

You’ll see antiarrhythmics used more often for “rhythm control” in some patients with atrial fib.

Older data found that reducing frequency and duration of atrial fib with antiarrhythmics doesn’t reduce mortality versus rate control with beta-blockers, CCBs, etc...and may increase hospitalizations.

Now data suggest that rhythm control may benefit patients with onset of atrial fib in the last year who are at high CV risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote